Fluprednisolone

CHEMBL1200774 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
378.4 g/mol
LogP
1.4
Phase
4

A synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties used to treat a range of inflammatory and allergic conditions. It works by inhibiting the production of inflammatory mediators throughout the body. Like other corticosteroids, prolonged use requires careful monitoring for systemic side effects.

분자량

378.4000 g/mol

LogP

1.40

TPSA

94.80 Ų

리핀스키 5의 법칙

통과

작용 기전

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

기전

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C[C@]12C=CC(=O)C=C1[C@@H](F)C[C@@H]1[C@@H]2[C@@H](O)C[C@@]2(C)[C@H]1CC[C@]2(O)C(=O)CO

InChI

InChI=1S/C21H27FO5/c1-19-5-3-11(24)7-14(19)15(22)8-12-13-4-6-21(27,17(26)10-23)20(13,2)9-16(25)18(12)19/h3,5,7,12-13,15-16,18,23,25,27H,4,6,8-10H2,1-2H3/t12-,13-,15-,16-,18+,19-,20-,21-/m0/s1

Molecular Formula

C21H27FO5

HBD / HBA

3 / 6

회전 가능 결합

2

무거운 원자

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties used to treat a range of inflammatory and allergic conditions. It works by inhibiting the production of inflammatory mediators throughout the body. Like other corticosteroids, prolonged use requires careful monitoring for systemic side effects.

Binds to intracellular glucocorticoid receptors, translocating to the nucleus to modulate gene transcription. This suppresses multiple inflammatory genes encoding cytokines, chemokines, and adhesion molecules while inducing anti-inflammatory proteins.

Yes, Fluprednisolone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200774. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5876. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.